Clinical course and analysis of ten fatal cases of clozapine-induced myocarditis and comparison with 66 surviving cases

Schizophrenia Research

Volumn 128, Issue 1-3, 2011, Pages 161-165

  Ronaldson, Kathlyn J ^a   Fitzgerald, Paul B ^a   Taylor, Andrew J ^b   Topliss, Duncan J ^b   McNeil, John J ^a  

^a MONASH UNIVERSITY   (Australia)

^b ALFRED HOSPITAL   (Australia)

Author keywords

Clozapine; Coronary artery disease; Drug hypersensitivity reaction; Fatality; Myocarditis; Schizophrenia

Indexed keywords

AMLODIPINE; ATENOLOL; BENZATROPINE; CLONAZEPAM; CLOZAPINE; CREATINE KINASE; DIAZEPAM; ESCITALOPRAM; GLIBENCLAMIDE; HALOPERIDOL; LACTULOSE; LITHIUM CARBONATE; METFORMIN; PROPRANOLOL; QUETIAPINE; SALBUTAMOL; TEMAZEPAM; THYROXINE; VALPROIC ACID; VENLAFAXINE;

ADULT; AGE DISTRIBUTION; ARTICLE; AUTOPSY; BODY MASS; CAUSE OF DEATH; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE COURSE; DRUG BLOOD LEVEL; DRUG FATALITY; FEMALE; FEVER; GENDER; HUMAN; HUMAN TISSUE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MYOCARDITIS; NEUROLEPTIC MALIGNANT SYNDROME; OBESITY; ONSET AGE; PRIORITY JOURNAL; SMOKING; TREATMENT DURATION; UPPER RESPIRATORY TRACT INFECTION;

ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; ANTIPSYCHOTIC AGENTS; BODY MASS INDEX; CARDIAC IMAGING TECHNIQUES; CLOZAPINE; FATAL OUTCOME; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDITIS; RETROSPECTIVE STUDIES; SCHIZOPHRENIA;

EID: 79955474912     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2011.01.017     Document Type: Article

References (24)

1. Annamraju S., Sheitman B., Saik S., Stephenson A. Early recognition of clozapine-induced myocarditis. J. Clin. Psychopharmacol. 2007, 27(5):479-483.
2. Australian Adverse Drug Reactions Advisory Committee Clozapine and myocarditis. Aust. Adverse Drug React. Bull. 1994, 13(4). Listed in the index for the journal, Internet:, Accessed 26 Nov 2010. http://www.tga.gov.au/adr/aadrb/aadrb_index.htm#c.
3. Committee on Safety of Medicines Myocarditis with antipsychotics: recent cases with clozapine (Clozaril). Curr. Probl. Pharmacovigilance 1993, 19(3):9-10. Internet:, Accessed 26 Nov 2010. http://www.mhra.gov.uk/home/idcplg?IdcService=GET_FILE&dDocName=CON2024456&RevisionSelectionMethod=LatestReleased.
4. Conley R.R., Shim J.-C., Kelly D.L., Feldman S., Yu Y., McMahon R.P. Cardiovascular disease in relation to weight in deceased persons with schizophrenia. Compr. Psychiatry 2005, 46(6):460-467.
5. Feldman A.M., McNamara D. Myocarditis. N. Engl. J. Med. 2000, 343(19):1388-1398.
6. Fineschi V., Neri M., Riezzo I., Turillazzi E. Sudden cardiac death due to hypersensitivity myocarditis during clozapine treatment. Int. J. Leg. Med. 2004, 118(5):307-309.
7. Flanagan R.J., Spencer E.P., Morgan P.E., Barnes T.R.E., Dunk L. Suspected clozapine poisoning in the UK/Eire, 1992-2003. Forensic Sci. Int. 2005, 155(2-3):91-99.
8. Haas S.J., Hill R., Krum H., Liew D., Tonkin A., Demos L., et al. Clozapine-associated myocarditis: A review of 116 cases of suspected myocarditis associated with the use of clozapine in Australia during 1993-2003. Drug Saf. 2007, 30(1):47-57.
9. Hagg S., Spigset O., Bate A., Soderstrom T.G. Myocarditis related to clozapine treatment. J. Clin. Psychopharmacol. 2001, 21(4):382-388.
10. Hill G.R., Harrison-Woolrych M. Clozapine and myocarditis: a case series from the New Zealand Intensive Medicines Monitoring Programme. NZ Med. J. 2008, 121(1281):68-74.
11. Kilian J.G., Kerr K., Lawrence C., Celermajer D.S. Myocarditis and cardiomyopathy associated with clozapine. Lancet 1999, 354(9193):1841-1845.
12. La Grenade L., Graham D., Trontell A. Myocarditis and cardiomyopathy associated with clozapine use in the United States. N. Engl. J. Med. 2001, 345(3):224-225.
13. Lee C.H., Tsai W.C., Hsu C.H., Liu P.Y., Lin L.J., Chen J.H. Predictive factors of a fulminant course in acute myocarditis. Int. J. Cardiol. 2006, 109(1):142-145.
14. Leucht S., Corves C., Arbter D., Engel R.R., Li C., Davis J.M. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet 2009, 373(9657):31-41.
15. Clozapine and myocarditis. Prescriber Update (9) 7-8. Referenced in: Medsafe Editorial Team, 2000. Potentially fatal complications of clozapine therapy: myocarditis, venous thromboembolism. Prescriber Update 1995, 20:14-18. Medsafe Editorial Team, Internet:, Accessed 26 Nov 2010. http://www.medsafe.govt.nz/profs/PUarticles/cloz1.htm.
16. Meeker J.E., Herrmann P.W., Som C.W., Reynolds P.C. Clozapine tissue concentrations following an apparent suicidal overdose of Clozaril. J. Anal. Toxicol. 1992, 16(1):54-56.
17. Meltzer H.Y., Alphs L., Green A.I., Altamura A.C., Anand R., Bertoldi A., et al. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Arch. Gen. Psychiatry 2003, 60(1):82-91.
18. Merrill D.B., Dec G.W., Goff D.C. Adverse cardiac effects associated with clozapine. J. Clin. Psychopharmacol. 2005, 25(1):32-41.
19. Ray W.A., Chung C.P., Murray K.T., Hall K., Stein M.C. Atypical antipsychotic drugs and the risk of sudden cardiac death. N. Engl. J. Med. 2009, 360(3):225-235.
20. Ronaldson K.J., Taylor A.J., Fitzgerald P.B., Topliss D.J., Elsik M., McNeil J.J. Diagnostic characteristics of clozapine induced myocarditis identified by an analysis of 38 cases and 47 controls. J. Clin. Psychol. 2010, 71(8):976-981.
21. Taylor D.M., Douglas-Hall P., Olofinjana B., Whiskey E., Thomas A. Reasons for discontinuing clozapine: matched, case-control comparison with risperidone long-acting injection. Br. J. Psychiatry 2009, 194(2):165-167.
22. Tiihonen J., Lonnqvist J., Wahlbeck K., Klaukka T., Niskanen L., Tanskanen A. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet 2009, 374(9690):620-627.
23. Tirupati S. Clozapine and heart in the Hunter region. Aust. NZ J. Psychiatry 2006, 40(1):97.
24. Walker A.M., Lanza L.L., Arellano F., Rothman K.J. Mortality in current and former users of clozapine. Epidemiology 1997, 8(6):671-677.